Unit Manager:
Barbara Theriot, MS
919-681-9099
Commercial Luminex assays (Magnetic or Non-magnetic)
-
Full service from sample to data (plasma, serum, cell supernatant, tissue homogenate, cerebrospinal fluid, lavage fluid…)
-
Assay read only (BioPlex 200, BioPlex FlexMap 3D, MagPix)
-
BSL2 and BSL3, Select Agents
Sample preparation
- Plasma, serum, or PBMC prep from whole blood
- Tissue specimen prep/homogenization
- Nucleic acid extraction
- Bead-based cell separation
ELISA
- Commercial kit
- Custom antigen-specific endpoint ELISAs
Real-time Thermocycler use
Quantitative signal joint T Cell Receptor Excision Circle (sjTREC) analysis (mouse, human, NHP)
Influenza Assay / Animal Model Request (form link)
- To be used by CIVICS investigators to submit requests for animal studies and RUO assay support
- Download required RUO assay sample submission manifest
Please Note: These links/forms are for the exclusive use of Duke CIVICS program investigators.
Use Fees/Rates
Current approved rates for Duke Investigators can be seen in CoreResearch@Duke (Core D-0002)
CoreResearch@Duke can also be used to request an ESTIMATE for grant or contract proposals
Service Requests and Estimates
Internal Duke users:
- How to submit a New Request (instructions)
External Non-Profit Institution users:
- A signed Research Analysis Quote and Agreement (RAQA) and Purchase Order (PO) will be needed from your institution
- Contact the RBL Immunology Unit for a price quote to get the process started.
Non-Duke For-Profit Entity users:
- Duke Shared Resources can only provide services to For-Profit Entities under a signed Sponsored Research Agreement (SRA)
- The collaborative research project must have a defined research question, scope of work, budget, and timeline.
- Contact the RBL Immunology Unit to get the process started
Luminex Assay Kit Finder Tool
Directions to the RBL and Parking Information (contact us)
How to acknowledge work done in our facility:
Please acknowledge our facility in any publications/presentations: “_____ was performed under the management of Barbara Theriot and direction of Dr. Andrew N. Macintyre in the Immunology Unit of the Duke Regional Biocontainment Laboratory (RBL), which received partial support for construction from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (UC6-AI058607; G20-AI167200).”